These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 2659720
1. Elemental diet: a therapeutic approach in chronic inflammatory bowel disease. Munkholm Larsen P, Rasmussen D, Rønn B, Munck O, Elmgreen J, Binder V. J Intern Med; 1989 May; 225(5):325-31. PubMed ID: 2659720 [Abstract] [Full Text] [Related]
2. Hypercatabolism of complement in Crohn's disease--assessment of circulating C3c. Elmgreen J, Berkowicz A, Sørensen H. Acta Med Scand; 1983 May; 214(5):403-7. PubMed ID: 6660048 [Abstract] [Full Text] [Related]
3. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. J Intern Med Suppl; 1989 May; 731():225-32. PubMed ID: 2650694 [Abstract] [Full Text] [Related]
4. Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease. Meister D, Ghosh S. World J Gastroenterol; 2005 Dec 21; 11(47):7466-72. PubMed ID: 16437718 [Abstract] [Full Text] [Related]
5. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Axelsson C, Jarnum S. Scand J Gastroenterol; 1977 Dec 21; 12(1):89-95. PubMed ID: 834975 [Abstract] [Full Text] [Related]
6. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Obih C, Wahbeh G, Lee D, Braly K, Giefer M, Shaffer ML, Nielson H, Suskind DL. Nutrition; 2016 Apr 21; 32(4):418-25. PubMed ID: 26655069 [Abstract] [Full Text] [Related]
7. [Diet therapy in chronic inflammatory bowel disease: results from meta-analysis and randomized controlled trials]. Galandi D, Allgaier HP. Praxis (Bern 1994); 2002 Nov 20; 91(47):2041-9. PubMed ID: 12501499 [Abstract] [Full Text] [Related]
8. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing. Chang J, Leong RW, Wasinger VC, Ip M, Yang M, Phan TG. Gastroenterology; 2017 Sep 20; 153(3):723-731.e1. PubMed ID: 28601482 [Abstract] [Full Text] [Related]
9. Diet therapy for inflammatory bowel diseases: The established and the new. Durchschein F, Petritsch W, Hammer HF. World J Gastroenterol; 2016 Feb 21; 22(7):2179-94. PubMed ID: 26900283 [Abstract] [Full Text] [Related]
10. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, Fellermann K, Schroeder JM, Stange EF. Inflamm Bowel Dis; 2003 Jul 21; 9(4):215-23. PubMed ID: 12902844 [Abstract] [Full Text] [Related]
11. Association of autonomic nervous hyperreflexia and systemic inflammation in patients with Crohn's disease and ulcerative colitis. Straub RH, Antoniou E, Zeuner M, Gross V, Schölmerich J, Andus T. J Neuroimmunol; 1997 Dec 21; 80(1-2):149-57. PubMed ID: 9413271 [Abstract] [Full Text] [Related]
12. The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic Review. Charlebois A, Rosenfeld G, Bressler B. Crit Rev Food Sci Nutr; 2016 Jun 10; 56(8):1370-8. PubMed ID: 25569442 [Abstract] [Full Text] [Related]
13. Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease. Suskind DL, Cohen SA, Brittnacher MJ, Wahbeh G, Lee D, Shaffer ML, Braly K, Hayden HS, Klein J, Gold B, Giefer M, Stallworth A, Miller SI. J Clin Gastroenterol; 2018 Feb 10; 52(2):155-163. PubMed ID: 28030510 [Abstract] [Full Text] [Related]
14. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA. J Pediatr Gastroenterol Nutr; 2007 May 10; 44(5):653-74. PubMed ID: 17460505 [Abstract] [Full Text] [Related]
15. A randomized, double-blind study of the effect of olestra on disease activity in patients with quiescent inflammatory bowel disease. Olestra in IBD Study Group. Zorich NL, Jones MB, Kesler JM, Carter SB, Sutton MA, Bayless T. Am J Med; 1997 Nov 10; 103(5):389-99. PubMed ID: 9375707 [Abstract] [Full Text] [Related]
16. Humoral immune system activity in inflammatory bowel disease. Teisberg P, Gjone E. Scand J Gastroenterol; 1975 Nov 10; 10(5):545-9. PubMed ID: 1171519 [Abstract] [Full Text] [Related]
17. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease. Winterkamp S, Weidenhiller M, Otte P, Stolper J, Schwab D, Hahn EG, Raithel M. Am J Gastroenterol; 2002 Dec 10; 97(12):3071-7. PubMed ID: 12492192 [Abstract] [Full Text] [Related]
18. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Brandhorst G, Weigand S, Eberle C, Raddatz D, Karaus M, Oellerich M, Walson PD. Clin Chim Acta; 2013 Jun 05; 421():31-3. PubMed ID: 23485644 [Abstract] [Full Text] [Related]
19. Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease. Elmgreen J, Sørensen H, Berkowicz A. Acta Med Scand; 1984 Jun 05; 215(4):375-8. PubMed ID: 6731047 [Abstract] [Full Text] [Related]
20. [Adjuvant therapy with elemental diet in chronic inflammatory intestinal diseases. Comparative study]. Rabast U, Heskamp R. Dtsch Med Wochenschr; 1986 Feb 21; 111(8):293-7. PubMed ID: 2868873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]